These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3865476

  • 1. Dissociation between kallikrein and aldosterone in Cushing's disease with periodic hormonogenesis.
    Overlack A, Higuchi M, Kolloch R, Müller HM, Stumpe KO, Schweikert HU.
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):296-301. PubMed ID: 3865476
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of aldosterone on kallikrein, prostaglandin E2 and sodium in rats.
    Yasujima M, Abe K, Tanno M, Kohzuki M, Kanazawa M, Omata K, Kasai Y, Sato M, Takeuchi K, Itoh S.
    Tohoku J Exp Med; 1987 Aug; 152(4):351-62. PubMed ID: 3477885
    [Abstract] [Full Text] [Related]

  • 3. Effect of aldosterone on urinary kallikrein and prostaglandin excretion in the rat.
    Fejes-Tóth G, Náray-Fejes-Tóth A.
    J Physiol; 1984 Sep; 354():79-88. PubMed ID: 6592330
    [Abstract] [Full Text] [Related]

  • 4. A circadian variation in the excretion of urinary kinin, kallikrein and prostaglandin E in normal volunteers.
    Abe K, Sato M, Kasai Y, Haruyama T, Sato K, Miyazaki S, Imai Y, Hiwatari M, Itoh T, Sakurai Y, Goto T, Tajima J, Seino M, Yoshinaga K.
    Jpn Circ J; 1981 Sep; 45(9):1098-103. PubMed ID: 7029030
    [Abstract] [Full Text] [Related]

  • 5. Urinary kallikrein, aldosterone, prostaglandin E2, sodium, potassium, and urinary volume in normal man-interrelations and day to day variation.
    Ohman KP, Karlberg BE.
    Acta Med Scand Suppl; 1983 Sep; 677():30-5. PubMed ID: 6584001
    [No Abstract] [Full Text] [Related]

  • 6. The prostaglandin and kallikrein-kinin systems in mineralocorticoid escape.
    Zipser RD, Zia P, Stone RA, Horton R.
    J Clin Endocrinol Metab; 1978 Nov; 47(5):996-1001. PubMed ID: 263798
    [Abstract] [Full Text] [Related]

  • 7. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K, Yasujima M, Chiba S, Sato M, Irokawa N, Imai Y, Yoshinaga K.
    Adv Exp Med Biol; 1979 Nov; 120B():487-501. PubMed ID: 517244
    [Abstract] [Full Text] [Related]

  • 8. Interrelations of the renal kallikrein-kinin system and renal prostaglandins in the conscious rat. Influence of mineralocorticoids.
    Nasjletti A, McGiff JC, Colina-Chourio J.
    Circ Res; 1978 Nov; 43(5):799-807. PubMed ID: 309362
    [Abstract] [Full Text] [Related]

  • 9. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
    Halushka PV, Wohltmann H, Privitera PJ, Hurwitz G, Margolius HS.
    Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
    [Abstract] [Full Text] [Related]

  • 10. Increased excretion of kallikrein during dexamethasone administration in normal man on low and normal salt intake.
    López JM, Arteaga E, Rodriguez JA, Croxatto H.
    Clin Sci (Lond); 1983 Nov; 65(5):487-90. PubMed ID: 6555065
    [Abstract] [Full Text] [Related]

  • 11. Urinary prostaglandin E2 and kallikrein excretion in glucocorticoid hypertension in rats.
    Handa M, Kondo K, Suzuki H, Saruta T.
    Clin Sci (Lond); 1983 Jul; 65(1):37-42. PubMed ID: 6342908
    [Abstract] [Full Text] [Related]

  • 12. Cyclic Cushing's syndrome combined with cortisol suppressible, dexamethasone non-suppressible ACTH secretion: a new variant of Cushing's syndrome.
    Schweikert HU, Fehm HL, Fahlbusch R, Martin R, Kolloch R, Higuchi M, Krück F.
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):289-95. PubMed ID: 3000118
    [Abstract] [Full Text] [Related]

  • 13. Effect of urinary pH and urine flow rate on prostaglandin E2 and kallikrein excretion by the conscious dog.
    Filep J, Földes-Filep E.
    J Physiol; 1987 Feb; 383():1-8. PubMed ID: 2821232
    [Abstract] [Full Text] [Related]

  • 14. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome.
    Saruta T, Suzuki H, Handa M, Igarashi Y, Kondo K, Senba S.
    J Clin Endocrinol Metab; 1986 Feb; 62(2):275-9. PubMed ID: 3510223
    [Abstract] [Full Text] [Related]

  • 15. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
    Lechi A, Mantero F, Opocher G, Armanini D, Lechi C, Covi G.
    J Endocrinol Invest; 1981 Feb; 4(1):17-20. PubMed ID: 7016967
    [Abstract] [Full Text] [Related]

  • 16. Mineralocorticoid escape during kallikrein inhibition.
    Overlack A, Bäcker-Kreutz E, Ressel C, Müller HM, Kolloch R, Stumpe KO.
    Clin Sci (Lond); 1986 Jan; 70(1):13-7. PubMed ID: 2417776
    [Abstract] [Full Text] [Related]

  • 17. Renal vasoactive hormones in scleroderma (progressive systemic sclerosis).
    Oliver JA, Vinci JM, Bowden RE, Weinberger AB, Baer L, Keiser HR, Cannon PJ.
    Nephron; 1981 Jan; 29(3-4):110-6. PubMed ID: 7035981
    [Abstract] [Full Text] [Related]

  • 18. Residual adrenocortical function after bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.
    Kemink L, Hermus A, Pieters G, Benraad T, Smals A, Kloppenborg P.
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1211-4. PubMed ID: 1331164
    [Abstract] [Full Text] [Related]

  • 19. Relationship of urinary kallikrein excretion to renal water and sodium excretion.
    Ueno M, Kawasaki T, Uezono K, Omae T, Matsuoka M.
    Metabolism; 1983 May; 32(5):433-7. PubMed ID: 6551657
    [Abstract] [Full Text] [Related]

  • 20. Urinary excretion of renal prostaglandins, kallikrein, vasopressin and aldosterone in essential hypertension.
    Favre L, Jornot L, Riondel A, Vallotton M.
    Clin Exp Hypertens A; 1983 May; 7(12):1663-79. PubMed ID: 3869481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.